Further analysis revealed that high lncRNA00544 expression was significantly associated with prognosis of the HER2−/HR + BC group (p < 0.001, Fig. 3D), but not with that of the HER2+/HR + BC group (p = 0.122, Fig. 3C). This evidence concerns the gene ERBB2 and breast cancer.